Arkolith/Insider Trading/ADIL/Form 4

Schuyler Kevin

Director, 10% OwnerADIAL PHARMACEUTICALS, INC. (ADIL) · full profile →Form 4 · filed Dec 23, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2021Gift(G)313K—$00

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 23, 2021Gift(G)90K—$00

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-21-067352) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML